From the Graduate School’s website: Information for CMP Students
Phase 2 continues a gradual expansion of research activities while ensuring we continue to follow guidelines to minimize the impacts of the COVID-19 pandemic. Please review the Public Health Protocols.
Significant changes in workplace practices are still expected from returning researchers in Phase 2. We will still require limitations on research site dynamics and building-level procedures to maintain physical distancing, minimize the total number of people in research spaces at any given time, reduce contact duration, develop capacity for contact tracing, and monitor for local instances of viral infection. Health safety protocols that follow government recommendations and best practices will be maintained throughout campus operations in Phase 2.
Phase 0, which was our initial response to COVID-19, was to move most research off campus. Only ‘essential’ research activities on campus were approved.
In Phase 1, which began in early June, a limited expansion of research activities were approved.
The Graduate School is committed to supporting graduate students in the in the many roles you hold, including as students, scholars, researchers, teachers, parents, and partners. Although COVID-19 has created challenges and changes that we all must contend with as a community, UW–Madison will continue to offer the exceptional graduate education, research experiences, and outreach for which we are known.
UW–Madison plans to begin fall classes as scheduled on Sept. 2 and offer in-person instruction in many courses until the Thanksgiving recess. After Thanksgiving, most undergraduate and course-based master’s classes will switch to a virtual format for courses for the final nine days of instruction plus exams. Research-based master’s and PhD degree students, as well as graduate assistants, should consult their faculty advisors and supervisors for additional guidance.
The course array and the modality of instruction will be determined by departments, working with the deans of their respective school or college. This will include course instruction plans for students not able to return to the U.S. for in-person instruction. Read the full announcement about fall semester operations.
The university is committed to reducing the risk of COVID-19 for its students, faculty, and staff. The Smart Restart plan outlines the university’s approach to dealing with major issues such as instruction, health and safety, and more.
Currently, for Fall 2020 we anticipate:
Path 802: held face to face
Path 803: Virtual
Path 751: Virtual
Path 900: Virtual
Path 901: Virtual
Path 990: Hybrid
Our mission is to train students for careers as independent investigators and teachers with a focus on basic cellular and molecular mechanisms of human disease.
- November 5
- November 12
- November 19
- December 3
- December 10
Welcome to our incoming Cellular and Molecular Pathology Graduate Training Program Class of 2020!
BS, Molecular/Cellular/Developmental Biology, University of Colorado Boulder
BS, Biochemistry/Chemical Engineering/Human Biology, North Carolina State University
BS, Biochemistry, University of Minnesota-Twin Cities
BS, Biological Sciences, Pennsylvania State University
BS, Biology, UW Madison
BS, Biology, SUNY Geneseo
Billy Erazo BS,
Industrial Microbiology, University of Puerto Rico
Trent Prall BS,
Genetics, UW Madison, (direct admission spring 2020)